{"id":"https://openalex.org/W2012210487","doi":"https://doi.org/10.2217/pgs.13.145","title":"Impact of Genotype-Guided Dosing on Anticoagulation Visits for Adults Starting Warfarin: A Randomized Controlled Trial","display_name":"Impact of Genotype-Guided Dosing on Anticoagulation Visits for Adults Starting Warfarin: A Randomized Controlled Trial","publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W2012210487","doi":"https://doi.org/10.2217/pgs.13.145","mag":"2012210487","pmid":"https://pubmed.ncbi.nlm.nih.gov/24088130"},"language":"en","primary_location":{"id":"doi:10.2217/pgs.13.145","doi":"https://doi.org/10.2217/pgs.13.145","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.145","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076399844","display_name":"Daniel E Jonas","orcid":"https://orcid.org/0000-0003-1964-8731","observed_orcids":["https://orcid.org/0000-0003-1964-8731"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E Jonas","raw_affiliation_strings":["Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, 5034 Old Clinic Building, CB #7110, Chapel Hill, NC27599, USA","University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, 5034 Old Clinic Building, CB #7110, Chapel Hill, NC27599, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070461219","display_name":"James P. Evans","orcid":"https://orcid.org/0000-0002-4080-8077","observed_orcids":["https://orcid.org/0000-0002-4080-8077"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P Evans","raw_affiliation_strings":["Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011034688","display_name":"Howard L. McLeod","orcid":"https://orcid.org/0000-0002-9004-9232","observed_orcids":["https://orcid.org/0000-0002-9004-9232"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard L McLeod","raw_affiliation_strings":["University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA","University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071511980","display_name":"Shannon Brode","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon Brode","raw_affiliation_strings":["Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","Hayes, Inc., Lansdale, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cecil G Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Hayes, Inc., Lansdale, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101822173","display_name":"Leslie A. Lange","orcid":"https://orcid.org/0000-0002-8077-4975","observed_orcids":["https://orcid.org/0000-0002-8077-4975"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie A Lange","raw_affiliation_strings":["Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mary L Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary L Young","raw_affiliation_strings":["Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027228130","display_name":"Betsy Bryant Shilliday","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betsy Bryant Shilliday","raw_affiliation_strings":["Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, 5034 Old Clinic Building, CB #7110, Chapel Hill, NC27599, USA","University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, 5034 Old Clinic Building, CB #7110, Chapel Hill, NC27599, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088719691","display_name":"Michelle Martensen Bardsley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Martensen Bardsley","raw_affiliation_strings":["University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067107201","display_name":"Nia J Swinton-Jenkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4387154109","display_name":"Hawaii Pacific Health","ror":"https://ror.org/05f5b3h44","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4387154109"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nia J Swinton-Jenkins","raw_affiliation_strings":["Hawaii Pacific Health Research Institute, Honolulu, HI, USA","University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hawaii Pacific Health Research Institute, Honolulu, HI, USA","institution_ids":["https://openalex.org/I4387154109"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018204002","display_name":"Karen E. Weck","orcid":"https://orcid.org/0000-0002-8516-333X","observed_orcids":["https://orcid.org/0000-0002-8516-333X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen E Weck","raw_affiliation_strings":["Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA","Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, NC, USA","University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genetics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"University of North Carolina at Chapel Hill Institute for Pharmacogenomics & Individualized Therapy, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.7301,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.98231791,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"14","issue":"13","first_page":"1593","last_page":"1603"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13984","display_name":"Nutrition, Genetics, and Disease","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/genotype-guided-dosing","display_name":"genotype-guided dosing","score":0.871999979019165},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/vkorc1","display_name":"VKORC1","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":1.0},{"id":"https://openalex.org/keywords/time-in-therapeutic-range","display_name":"time in therapeutic range","score":0.9559999704360962},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.3709999918937683},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.7850000262260437},{"id":"https://openalex.org/keywords/thrombotic-complications","display_name":"thrombotic complications","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.5049999952316284},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.8130000233650208},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8835686445236206},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8025596141815186},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.7942026257514954},{"id":"https://openalex.org/C2776318485","wikidata":"https://www.wikidata.org/wiki/Q18045930","display_name":"VKORC1","level":5,"score":0.6311419010162354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6187905073165894},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.47958651185035706},{"id":"https://openalex.org/C2776765323","wikidata":"https://www.wikidata.org/wiki/Q82305736","display_name":"Vitamin K epoxide reductase","level":5,"score":0.46660491824150085},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4078425467014313},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.40239715576171875},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.39322254061698914},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3715478181838989},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3309062421321869},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1565607190132141},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.08606433868408203},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.056030482053756714},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019934","descriptor_name":"International Normalized Ratio","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064417","descriptor_name":"Vitamin K Epoxide Reductases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2217/pgs.13.145","doi":"https://doi.org/10.2217/pgs.13.145","is_oa":false,"landing_page_url":"https://doi.org/10.2217/pgs.13.145","pdf_url":null,"source":{"id":"https://openalex.org/S190377370","display_name":"Pharmacogenomics","issn_l":"1462-2416","issn":["1462-2416","1744-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"journal-article"},{"id":"pmid:24088130","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24088130","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenomics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1515782956","https://openalex.org/W1586488555","https://openalex.org/W1977280638","https://openalex.org/W1983011741","https://openalex.org/W1994894525","https://openalex.org/W1998269707","https://openalex.org/W2006566690","https://openalex.org/W2006640042","https://openalex.org/W2017538702","https://openalex.org/W2025144228","https://openalex.org/W2032289591","https://openalex.org/W2066490209","https://openalex.org/W2068476516","https://openalex.org/W2078517865","https://openalex.org/W2110229609","https://openalex.org/W2112940339","https://openalex.org/W2118654837","https://openalex.org/W2122666241","https://openalex.org/W2126415810","https://openalex.org/W2147905647","https://openalex.org/W2148215987","https://openalex.org/W2151936813","https://openalex.org/W2157065952","https://openalex.org/W2167473711","https://openalex.org/W2170483665"],"related_works":["https://openalex.org/W2757093235","https://openalex.org/W2059373548","https://openalex.org/W2128189669","https://openalex.org/W2157839219","https://openalex.org/W1978140999","https://openalex.org/W7213880156","https://openalex.org/W6942485424","https://openalex.org/W1971920221","https://openalex.org/W2063015008","https://openalex.org/W2157065952"],"abstract_inverted_index":{"AIM:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,22,67,159],"assess":[5],"the":[6,47,53,122,129,146],"effectiveness":[7],"of":[8,17,49,73,148],"genotype-guided":[9],"warfarin":[10],"dosing.":[11],"PATIENTS":[12],"&":[13],"METHODS:":[14],"A":[15],"total":[16],"109":[18],"adults":[19],"were":[20,46,136],"randomized":[21],"receive":[23],"initial":[24],"dosing":[25,142],"as":[26],"determined":[27],"by":[28],"an":[29],"algorithm":[30],"containing":[31],"genetic":[32,123],"(VKORC1":[33],"and":[34,52,82,118,167],"CYP2C9)":[35],"plus":[36,124],"clinical":[37,41,125,130],"information":[38],"or":[39,151],"only":[40,131],"information.":[42],"Primary":[43],"end":[44,63,87],"points":[45,64],"number":[48,147],"anticoagulation":[50,149],"visits":[51,150],"time":[54,66],"in":[55,121,128],"therapeutic":[56,68],"range":[57],"(TTR)":[58],"over":[59],"90":[60],"days.":[61],"Secondary":[62],"included":[65],"dose,":[69],"International":[70],"Normalized":[71],"Ratios":[72],">4,":[74],"emergency":[75,110],"visits,":[76,111],"hospitalizations,":[77,112],"hemorrhagic":[78,114],"events,":[79,115],"thrombotic":[80,116],"events":[81,117],"mortality.":[83],"RESULTS:":[84],"Neither":[85],"primary":[86],"point":[88],"was":[89,156],"significantly":[90],"different":[91],"between":[92],"groups":[93],"(anticoagulation":[94],"visits:":[95],"6.96":[96],"vs":[97,104],"6.37,":[98],"p":[99,106],"=":[100,107],"0.51;":[101],"TTR:":[102],"0.40":[103],"0.43,":[105],"0.59).":[108],"Fewer":[109],"major":[113],"deaths":[119],"occurred":[120],"group":[126],"than":[127],"group,":[132],"but":[133,162],"these":[134],"differences":[135,164],"not":[137,144,157],"statistically":[138],"significant.":[139],"CONCLUSION:":[140],"Genotype-guided":[141],"did":[143],"decrease":[145],"improve":[152],"TTR.":[153],"Our":[154],"trial":[155],"powered":[158],"detect":[160],"anything":[161],"large":[163],"for":[165],"utilization":[166],"health":[168],"outcomes.":[169]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}